Bellicum Pharmaceuticals Inc. (BLCM) OTC MARKETS
$0.20 0 (0.40%)
Market Cap: $1.95M
As of 12/08/23 04:00 PM EST. Market closed.
Bellicum Pharmaceuticals Inc. (BLCM)
OTC MARKETS
$0.20
0 (0.40%)
Market Cap: $1.95M
As of 12/08/23 04:00 PM EST. Market closed.
Add to Portfolio
bellicum pharmaceuticals, located near the houston medical center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. we are developing next-generation product candidates in some of the most important areas of ... read more
bellicum pharmaceuticals, located near the houston medical center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. we are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (hsct) and car t cell therapy. we are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Richard Fair
Full Time Employees
43
CEO Compensation (Base)
$551,050
CEO Compensation (Total)
$3.28M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Richard Fair
Full Time Employees
43
CEO Compensation (Base)
$551,050
CEO Compensation (Total)
$3.28M
URL
Address
2710 Reed Road, Suite 160, Texas, Houston, 77051.
PRICE CHART FOR BELLICUM PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.20
Days Range
$0.20 - $0.25
52 week range
$0.06 - $0.59
Volume
11,815
Avg. Volume (30 days)
21,280
Market Cap
$1.95M
Dividend Yield
-
P/E
-
Shares Outstanding
9,716,931
Open
-
Previous Close
$0.20
Days Range
$0.20 - $0.25
52 week range
$0.06 - $0.59
Volume
11,815
Avg. Volume (30 days)
21,280
Market Cap
$1.95M
Dividend Yield
-
P/E
-
Shares Outstanding
9,716,931
FINANCIAL STATEMENTS FOR BELLICUM PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BELLICUM PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BAKER BROS. ADVISORS LP | 10% Owner | Nov 22, 2023 | Option Exercise | $0.00 | 2,116,349 | 212 | 2,168,818 | Nov 24, 2023, 01:39 PM |
| Ward Shane | Sr VP and Chief Legal SO | May 29, 2020 | Option Exercise | $7.63 | 107 | 816 | 1,879 | Jun 02, 2020, 12:25 PM |
| Fair Richard A. | President and CEO | Mar 17, 2020 | Buy | $4.00 | 5,000 | 19,999 | 5,000 | Mar 19, 2020, 12:48 PM |
| Williams Rosemary Y. | VP, Finance & PAO | Jan 03, 2020 | Option Exercise | $1.40 | 295 | 413 | 5,756 | Jan 06, 2020, 05:15 PM |
| Williams Rosemary Y. | VP, Finance & PAO | Jan 02, 2020 | Option Exercise | $1.51 | 483 | 729 | 5,270 | Jan 06, 2020, 05:15 PM |
| Smith Alan K. | EVP, Technical Operations | Jan 03, 2020 | Option Exercise | $1.40 | 589 | 825 | 6,956 | Jan 06, 2020, 05:00 PM |
| Smith Alan K. | EVP, Technical Operations | Jan 02, 2020 | Option Exercise | $1.51 | 883 | 1,333 | 5,982 | Jan 06, 2020, 05:00 PM |
| Foster Aaron E. | Sr VP, Head of Research | Jan 03, 2020 | Option Exercise | $1.40 | 236 | 330 | 7,281 | Jan 06, 2020, 04:29 PM |
| Foster Aaron E. | Sr VP, Head of Research | Jan 02, 2020 | Option Exercise | $1.51 | 942 | 1,422 | 6,892 | Jan 06, 2020, 04:29 PM |
| Woodard Jr Joseph Paul | SVP Clinical & Medical Affairs | Nov 13, 2019 | Option Exercise | $0.82 | 1,597 | 1,310 | 5,467 | Nov 14, 2019, 05:11 PM |
| Fair Richard A. | President and CEO | Sep 10, 2019 | Buy | $1.25 | 40,000 | 50,000 | 66,561 | Sep 11, 2019, 07:01 PM |
| Ward Shane | Sr. VP and General Counsel | Aug 29, 2019 | Buy | $1.23 | 8,000 | 9,822 | 18,294 | Aug 30, 2019, 04:01 PM |
| Naeve Gregory S. | Chief Business Officer | Aug 21, 2019 | Option Exercise | $0.95 | 1,597 | 1,513 | 13,746 | Aug 23, 2019, 04:04 PM |
| Fair Richard A. | President and CEO | Aug 21, 2019 | Buy | $0.99 | 20,000 | 19,780 | 26,561 | Aug 23, 2019, 04:03 PM |
| Ward Shane | Sr. VP and General Counsel | May 29, 2019 | Option Exercise | $2.09 | 1,065 | 2,226 | 8,935 | May 30, 2019, 04:05 PM |
| Grossman William | Sr. VP, Chief Medical Officer | Feb 05, 2019 | Option Exercise | $3.48 | 3,126 | 10,878 | 26,874 | Feb 07, 2019, 04:02 PM |
| Naeve Gregory S. | Chief Business Officer | Jan 02, 2019 | Option Exercise | $3.33 | 993 | 3,307 | 14,441 | Jan 04, 2019, 04:03 PM |
| Williams Rosemary Y. | Principal Accounting Officer | Jan 03, 2019 | Option Exercise | $3.20 | 295 | 944 | 4,471 | Jan 04, 2019, 04:03 PM |
| Williams Rosemary Y. | Principal Accounting Officer | Jan 02, 2019 | Option Exercise | $3.33 | 483 | 1,608 | 3,984 | Jan 04, 2019, 04:03 PM |
| Smith Alan K. | EVP, Technical Operations | Jan 03, 2019 | Option Exercise | $3.20 | 589 | 1,885 | 4,521 | Jan 04, 2019, 04:01 PM |
| Smith Alan K. | EVP, Technical Operations | Jan 02, 2019 | Option Exercise | $3.33 | 883 | 2,940 | 3,548 | Jan 04, 2019, 04:01 PM |
| Spencer David M. | Chief Technology Officer | Jan 03, 2019 | Option Exercise | $3.20 | 589 | 1,885 | 92,470 | Jan 04, 2019, 12:00 AM |
| Spencer David M. | Chief Technology Officer | Jan 02, 2019 | Option Exercise | $3.33 | 942 | 3,137 | 91,497 | Jan 04, 2019, 12:00 AM |
| Stonehouse Jon P | Director | Nov 09, 2018 | Buy | $4.56 | 10,000 | 45,600 | 10,000 | Nov 13, 2018, 04:01 PM |
| Spencer David M. | Chief Technology Officer | Sep 04, 2018 | Sale | $7.04 | 10,000 | 70,413 | 89,939 | Sep 05, 2018, 04:02 PM |
| Naeve Gregory S. | Chief Business Officer | Aug 21, 2018 | Option Exercise | $6.74 | 1,597 | 10,764 | 13,403 | Aug 23, 2018, 04:03 PM |
| Spencer David M. | Chief Technology Officer | Jul 18, 2018 | Sale | $7.63 | 40,000 | 305,132 | 99,939 | Jul 20, 2018, 04:01 PM |
| Musso Alan A | CFO and Treasurer | May 25, 2018 | Sale | $7.97 | 6,206 | 49,466 | 26,548 | May 29, 2018, 04:49 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 19, 2018 | Sale | $7.91 | 295,361 | 2,336,217 | 3,734,776 | Jan 19, 2018, 04:57 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 18, 2018 | Sale | $8.12 | 324,774 | 2,635,768 | 4,000,484 | Jan 19, 2018, 04:57 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 17, 2018 | Sale | $8.63 | 260,600 | 2,247,910 | 4,292,652 | Jan 19, 2018, 04:57 PM |
| Smith Alan K. | EVP, Technical Operations | Jan 09, 2018 | Sale | $9.40 | 487 | 4,578 | 2,087 | Jan 11, 2018, 04:02 PM |
| Musso Alan A | CFO and Treasurer | Jan 03, 2018 | Option Exercise | $9.79 | 706 | 6,912 | 32,754 | Jan 05, 2018, 04:04 PM |
| Spencer David M. | Chief Scientific Officer | Jan 03, 2018 | Option Exercise | $9.79 | 589 | 5,766 | 139,939 | Jan 05, 2018, 04:03 PM |
| Smith Alan K. | EVP, Technical Operations | Jan 03, 2018 | Option Exercise | $9.79 | 589 | 5,766 | 2,574 | Jan 05, 2018, 04:03 PM |
| Moseley Ken | Sr. VP and General Counsel | Jan 03, 2018 | Option Exercise | $9.79 | 589 | 5,766 | 1,465 | Jan 05, 2018, 04:03 PM |
| Musso Alan A | CFO and Treasurer | Dec 11, 2017 | Sale | $9.33 | 17,117 | 159,667 | 31,585 | Dec 13, 2017, 04:05 PM |
| Musso Alan A | CFO and Treasurer | Nov 27, 2017 | Sale | $9.89 | 6,206 | 61,382 | 48,702 | Nov 29, 2017, 05:06 PM |
| Smith Alan K. | EVP, Technical Operations | Jul 24, 2017 | Sale | $11.85 | 437 | 5,178 | 1,600 | Jul 26, 2017, 04:29 PM |
| Moseley Ken | Sr. VP and General Counsel | Jul 13, 2017 | Option Exercise | $2.55 | 13,823 | 35,249 | 14,314 | Jul 17, 2017, 04:20 PM |
| Moseley Ken | Sr. VP and General Counsel | Jul 13, 2017 | Sale | $12.26 | 13,823 | 169,470 | 491 | Jul 17, 2017, 04:20 PM |
| Spencer David M. | Chief Scientific Officer | Jul 10, 2017 | Sale | $11.54 | 10,000 | 115,400 | 138,965 | Jul 12, 2017, 04:43 PM |
| Musso Alan A | CFO and Treasurer | May 25, 2017 | Sale | $12.24 | 6,311 | 77,254 | 54,908 | May 26, 2017, 03:07 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Mar 24, 2017 | Buy | $12.00 | 166,666 | 1,999,992 | 4,527,089 | Mar 28, 2017, 05:05 PM |
| Slawin Kevin M. | Director | Feb 07, 2017 | Sale | $12.54 | 30,000 | 376,215 | 294,982 | Feb 09, 2017, 04:11 PM |
| Slawin Kevin M. | Chief Technology Officer | Dec 15, 2016 | Sale | $15.45 | 30,000 | 463,539 | 324,982 | Dec 19, 2016, 04:13 PM |
| Spencer David M. | Chief Scientific Officer | Dec 05, 2016 | Sale | $20.00 | 5,000 | 100,000 | 146,082 | Dec 05, 2016, 06:42 PM |
| Spencer David M. | Chief Scientific Officer | Dec 01, 2016 | Sale | $17.52 | 5,000 | 87,624 | 153,115 | Dec 05, 2016, 04:09 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Dec 01, 2016 | Option Exercise | $2.55 | 25,000 | 63,750 | 25,442 | Dec 05, 2016, 04:07 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Dec 01, 2016 | Sale | $17.54 | 25,000 | 438,505 | 10,984 | Dec 05, 2016, 04:07 PM |
| Musso Alan A | CFO and Treasurer | Nov 28, 2016 | Sale | $19.25 | 23,027 | 443,160 | 61,148 | Nov 29, 2016, 04:05 PM |
| Musso Alan A | CFO and Treasurer | Nov 25, 2016 | Sale | $20.48 | 6,273 | 128,480 | 83,575 | Nov 29, 2016, 04:05 PM |
| Spencer David M. | Chief Scientific Officer | Sep 23, 2016 | Sale | $20.19 | 6,200 | 125,172 | 156,082 | Sep 23, 2016, 06:57 PM |
| Spencer David M. | Chief Scientific Officer | Sep 22, 2016 | Sale | $19.68 | 10,000 | 196,832 | 162,282 | Sep 23, 2016, 06:57 PM |
| Spencer David M. | Chief Scientific Officer | Sep 21, 2016 | Sale | $20.04 | 300 | 6,012 | 172,282 | Sep 23, 2016, 06:57 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 23, 2016 | Sale | $20.11 | 11,958 | 240,530 | 354,982 | Sep 23, 2016, 06:56 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 23, 2016 | Sale | $20.12 | 11,258 | 226,549 | 84,206 | Sep 23, 2016, 06:56 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 21, 2016 | Sale | $20.04 | 100 | 2,004 | 366,940 | Sep 23, 2016, 06:56 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 21, 2016 | Sale | $20.04 | 100 | 2,004 | 95,464 | Sep 23, 2016, 06:56 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 23, 2016 | Option Exercise | $7.47 | 11,700 | 87,399 | 12,044 | Sep 23, 2016, 06:55 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 21, 2016 | Option Exercise | $7.47 | 100 | 747 | 444 | Sep 23, 2016, 06:55 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 23, 2016 | Sale | $20.10 | 11,700 | 235,198 | 344 | Sep 23, 2016, 06:55 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 21, 2016 | Sale | $20.04 | 100 | 2,004 | 344 | Sep 23, 2016, 06:55 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 19, 2016 | Sale | $20.02 | 1,400 | 28,024 | 95,864 | Sep 20, 2016, 06:21 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 16, 2016 | Sale | $20.00 | 636 | 12,720 | 368,346 | Sep 20, 2016, 06:21 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 16, 2016 | Sale | $20.00 | 942 | 18,840 | 97,264 | Sep 20, 2016, 06:21 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 20, 2016 | Sale | $20.00 | 100 | 2,000 | 367,040 | Sep 20, 2016, 06:21 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 20, 2016 | Sale | $20.00 | 300 | 6,000 | 95,564 | Sep 20, 2016, 06:21 PM |
| Slawin Kevin M. | Chief Technology Officer | Sep 19, 2016 | Sale | $20.01 | 1,206 | 24,129 | 367,140 | Sep 20, 2016, 06:21 PM |
| Spencer David M. | Chief Scientific Officer | Sep 20, 2016 | Sale | $20.00 | 100 | 2,000 | 172,582 | Sep 20, 2016, 06:20 PM |
| Spencer David M. | Chief Scientific Officer | Sep 19, 2016 | Sale | $20.02 | 700 | 14,013 | 172,682 | Sep 20, 2016, 06:20 PM |
| Spencer David M. | Chief Scientific Officer | Sep 16, 2016 | Sale | $20.01 | 1,700 | 34,015 | 173,382 | Sep 20, 2016, 06:20 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 19, 2016 | Option Exercise | $7.47 | 1,300 | 9,711 | 1,644 | Sep 20, 2016, 06:19 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 16, 2016 | Option Exercise | $7.47 | 700 | 5,229 | 1,044 | Sep 20, 2016, 06:19 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 20, 2016 | Option Exercise | $7.47 | 200 | 1,494 | 544 | Sep 20, 2016, 06:19 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 16, 2016 | Sale | $20.00 | 700 | 14,000 | 344 | Sep 20, 2016, 06:19 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 20, 2016 | Sale | $20.00 | 200 | 4,000 | 344 | Sep 20, 2016, 06:19 PM |
| Moseley Ken | Sr. VP and General Counsel | Sep 19, 2016 | Sale | $20.01 | 1,300 | 26,018 | 344 | Sep 20, 2016, 06:19 PM |
| Slawin Kevin M. | Chief Technology Officer | Aug 15, 2016 | Sale | $19.32 | 31,000 | 598,931 | 370,982 | Aug 17, 2016, 04:11 PM |
| Slawin Kevin M. | Chief Technology Officer | Aug 15, 2016 | Sale | $19.31 | 36,000 | 695,012 | 100,079 | Aug 17, 2016, 04:11 PM |
| Spencer David M. | Chief Scientific Officer | Aug 15, 2016 | Sale | $20.00 | 1,000 | 20,000 | 175,082 | Aug 17, 2016, 04:09 PM |
| Moseley Ken | Sr. VP and General Counsel | Aug 15, 2016 | Option Exercise | $7.47 | 1,000 | 7,470 | 1,344 | Aug 17, 2016, 04:09 PM |
| Moseley Ken | Sr. VP and General Counsel | Aug 15, 2016 | Sale | $20.00 | 1,000 | 20,000 | 344 | Aug 17, 2016, 04:09 PM |
| Slawin Kevin M. | Chief Technology Officer | Jul 27, 2016 | Sale | $15.00 | 15,000 | 225,000 | 399,982 | Jul 29, 2016, 05:50 PM |
| Spencer David M. | Chief Scientific Officer | Jul 27, 2016 | Sale | $15.00 | 10,000 | 150,000 | 176,082 | Jul 29, 2016, 05:48 PM |
| Slawin Kevin M. | Chief Technology Officer | Jul 18, 2016 | Sale | $13.99 | 2,719 | 38,044 | 134,206 | Jul 19, 2016, 06:42 PM |
| Slawin Kevin M. | Chief Technology Officer | Jul 15, 2016 | Sale | $13.72 | 22,281 | 305,677 | 136,925 | Jul 19, 2016, 04:02 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Jun 02, 2016 | Option Exercise | $2.55 | 25,000 | 63,750 | 18,486 | Jun 06, 2016, 04:06 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Jun 02, 2016 | Sale | $13.00 | 25,000 | 325,000 | 251 | Jun 06, 2016, 04:06 PM |
| Moseley Ken | Sr. VP and General Counsel | Jun 02, 2016 | Option Exercise | $2.55 | 15,000 | 38,250 | 15,196 | Jun 06, 2016, 04:06 PM |
| Moseley Ken | Sr. VP and General Counsel | Jun 02, 2016 | Sale | $13.00 | 15,000 | 195,000 | 196 | Jun 06, 2016, 04:06 PM |
| Slawin Kevin M. | Chief Technology Officer | Apr 22, 2016 | Sale | $11.43 | 30,000 | 342,788 | 415,182 | Apr 26, 2016, 04:06 PM |
| Slawin Kevin M. | Chief Technology Officer | Apr 22, 2016 | Sale | $11.43 | 25,000 | 285,710 | 159,206 | Apr 26, 2016, 04:06 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Jan 04, 2016 | Option Exercise | $2.55 | 35,000 | 89,250 | 35,251 | Jan 06, 2016, 04:20 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Jan 04, 2016 | Sale | $19.07 | 35,000 | 667,494 | 2,551 | Jan 06, 2016, 04:20 PM |
| Spencer David M. | Chief Scientific Officer | Dec 14, 2015 | Option Exercise | $2.55 | 5,000 | 12,750 | 184,559 | Dec 16, 2015, 04:04 PM |
| Spencer David M. | Chief Scientific Officer | Dec 01, 2015 | Sale | $22.95 | 5,000 | 114,739 | 178,600 | Dec 03, 2015, 04:16 PM |
| Musso Alan A | CFO and Treasurer | Nov 24, 2015 | Sale | $22.34 | 29,300 | 654,459 | 88,742 | Nov 27, 2015, 04:50 PM |
| Slawin Kevin M. | Chief Technology Officer | Nov 16, 2015 | Sale | $20.65 | 4,000 | 82,585 | 398,066 | Nov 18, 2015, 11:44 AM |
| Slawin Kevin M. | Chief Technology Officer | Nov 16, 2015 | Sale | $20.65 | 14,000 | 289,047 | 444,981 | Nov 18, 2015, 11:44 AM |
| Slawin Kevin M. | Chief Technology Officer | Nov 16, 2015 | Sale | $20.65 | 6,000 | 123,877 | 184,206 | Nov 18, 2015, 11:44 AM |
| Moseley Ken | Sr. VP and General Counsel | Nov 02, 2015 | Option Exercise | $2.55 | 15,000 | 38,250 | 15,097 | Nov 04, 2015, 01:36 PM |
| Moseley Ken | Sr. VP and General Counsel | Nov 02, 2015 | Sale | $13.00 | 15,000 | 195,000 | 97 | Nov 04, 2015, 01:36 PM |
| Farrell Thomas J. | President and CEO | Oct 01, 2015 | Sale | $14.58 | 2,500 | 36,442 | 63,862 | Oct 06, 2015, 06:11 AM |
| Spencer David M. | Chief Scientific Officer | Sep 21, 2015 | Option Exercise | $2.55 | 5,000 | 12,750 | 183,600 | Sep 23, 2015, 05:14 PM |
| Spencer David M. | Chief Scientific Officer | Sep 11, 2015 | Sale | $19.00 | 5,000 | 95,000 | 178,600 | Sep 15, 2015, 04:11 PM |
| Farrell Thomas J. | President and CEO | Sep 01, 2015 | Sale | $16.78 | 2,500 | 41,943 | 66,362 | Sep 03, 2015, 04:55 PM |
| Farrell Thomas J. | President and CEO | Aug 03, 2015 | Sale | $20.24 | 2,500 | 50,608 | 68,862 | Aug 05, 2015, 05:07 PM |
| Slawin Kevin M. | Chief Technology Officer | Jul 15, 2015 | Sale | $20.00 | 1,500 | 30,000 | 163,008 | Jul 17, 2015, 04:59 PM |
| Slawin Kevin M. | Chief Technology Officer | Jul 15, 2015 | Sale | $20.00 | 1,000 | 20,000 | 402,066 | Jul 17, 2015, 04:59 PM |
| Slawin Kevin M. | Chief Technology Officer | Jul 15, 2015 | Sale | $20.00 | 3,500 | 70,000 | 458,981 | Jul 17, 2015, 04:59 PM |
| Spencer David M. | Chief Scientific Officer | Jul 02, 2015 | Option Exercise | $2.55 | 20,000 | 51,000 | 183,600 | Jul 07, 2015, 04:59 PM |
| Moseley Ken | Sr. VP and General Counsel | Jul 01, 2015 | Option Exercise | $2.55 | 15,000 | 38,250 | 15,097 | Jul 06, 2015, 05:00 PM |
| Moseley Ken | Sr. VP and General Counsel | Jul 01, 2015 | Sale | $20.62 | 15,000 | 309,267 | 547 | Jul 06, 2015, 05:00 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Jul 01, 2015 | Option Exercise | $2.55 | 35,000 | 89,250 | 35,122 | Jul 06, 2015, 04:59 PM |
| Moseley Annemarie | COO/EVP Clinical Development | Jul 01, 2015 | Sale | $20.62 | 35,000 | 721,622 | 1,172 | Jul 06, 2015, 04:59 PM |
| Spencer David M. | Chief Scientific Officer | Jun 16, 2015 | Sale | $22.96 | 20,000 | 459,173 | 166,400 | Jun 19, 2015, 05:06 PM |
| Spencer David M. | Chief Scientific Officer | Jun 16, 2015 | Sale | $22.96 | 20,000 | 459,173 | 165,554 | Jun 18, 2015, 05:03 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| BAKER BROS. ADVISORS LP | 10% Owner | 11/22/2023 | 212 |
| Ward Shane | Sr VP and Chief Legal SO | 05/29/2020 | 816 |
| Fair Richard A. | President and CEO | 03/17/2020 | 19,999 |
| Williams Rosemary Y. | VP, Finance & PAO | 01/03/2020 | 413 |
| Williams Rosemary Y. | VP, Finance & PAO | 01/02/2020 | 729 |
| Smith Alan K. | EVP, Technical Operations | 01/03/2020 | 825 |
| Smith Alan K. | EVP, Technical Operations | 01/02/2020 | 1,333 |
| Foster Aaron E. | Sr VP, Head of Research | 01/03/2020 | 330 |
| Foster Aaron E. | Sr VP, Head of Research | 01/02/2020 | 1,422 |
| Woodard Jr Joseph Paul | SVP Clinical & Medical Affairs | 11/13/2019 | 1,310 |
| Fair Richard A. | President and CEO | 09/10/2019 | 50,000 |
| Ward Shane | Sr. VP and General Counsel | 08/29/2019 | 9,822 |
| Naeve Gregory S. | Chief Business Officer | 08/21/2019 | 1,513 |
| Fair Richard A. | President and CEO | 08/21/2019 | 19,780 |
| Ward Shane | Sr. VP and General Counsel | 05/29/2019 | 2,226 |
| Grossman William | Sr. VP, Chief Medical Officer | 02/05/2019 | 10,878 |
| Naeve Gregory S. | Chief Business Officer | 01/02/2019 | 3,307 |
| Williams Rosemary Y. | Principal Accounting Officer | 01/03/2019 | 944 |
| Williams Rosemary Y. | Principal Accounting Officer | 01/02/2019 | 1,608 |
| Smith Alan K. | EVP, Technical Operations | 01/03/2019 | 1,885 |
| Smith Alan K. | EVP, Technical Operations | 01/02/2019 | 2,940 |
| Spencer David M. | Chief Technology Officer | 01/03/2019 | 1,885 |
| Spencer David M. | Chief Technology Officer | 01/02/2019 | 3,137 |
| Stonehouse Jon P | Director | 11/09/2018 | 45,600 |
| Spencer David M. | Chief Technology Officer | 09/04/2018 | 70,413 |
| Naeve Gregory S. | Chief Business Officer | 08/21/2018 | 10,764 |
| Spencer David M. | Chief Technology Officer | 07/18/2018 | 305,132 |
| Musso Alan A | CFO and Treasurer | 05/25/2018 | 49,466 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/19/2018 | 2,336,217 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/18/2018 | 2,635,768 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/17/2018 | 2,247,910 |
| Smith Alan K. | EVP, Technical Operations | 01/09/2018 | 4,578 |
| Musso Alan A | CFO and Treasurer | 01/03/2018 | 6,912 |
| Spencer David M. | Chief Scientific Officer | 01/03/2018 | 5,766 |
| Smith Alan K. | EVP, Technical Operations | 01/03/2018 | 5,766 |
| Moseley Ken | Sr. VP and General Counsel | 01/03/2018 | 5,766 |
| Musso Alan A | CFO and Treasurer | 12/11/2017 | 159,667 |
| Musso Alan A | CFO and Treasurer | 11/27/2017 | 61,382 |
| Smith Alan K. | EVP, Technical Operations | 07/24/2017 | 5,178 |
| Moseley Ken | Sr. VP and General Counsel | 07/13/2017 | 35,249 |
| Moseley Ken | Sr. VP and General Counsel | 07/13/2017 | 169,470 |
| Spencer David M. | Chief Scientific Officer | 07/10/2017 | 115,400 |
| Musso Alan A | CFO and Treasurer | 05/25/2017 | 77,254 |
| BAKER BROS. ADVISORS LP | 10% Owner | 03/24/2017 | 1,999,992 |
| Slawin Kevin M. | Director | 02/07/2017 | 376,215 |
| Slawin Kevin M. | Chief Technology Officer | 12/15/2016 | 463,539 |
| Spencer David M. | Chief Scientific Officer | 12/05/2016 | 100,000 |
| Spencer David M. | Chief Scientific Officer | 12/01/2016 | 87,624 |
| Moseley Annemarie | COO/EVP Clinical Development | 12/01/2016 | 63,750 |
| Moseley Annemarie | COO/EVP Clinical Development | 12/01/2016 | 438,505 |
| Musso Alan A | CFO and Treasurer | 11/28/2016 | 443,160 |
| Musso Alan A | CFO and Treasurer | 11/25/2016 | 128,480 |
| Spencer David M. | Chief Scientific Officer | 09/23/2016 | 125,172 |
| Spencer David M. | Chief Scientific Officer | 09/22/2016 | 196,832 |
| Spencer David M. | Chief Scientific Officer | 09/21/2016 | 6,012 |
| Slawin Kevin M. | Chief Technology Officer | 09/23/2016 | 240,530 |
| Slawin Kevin M. | Chief Technology Officer | 09/23/2016 | 226,549 |
| Slawin Kevin M. | Chief Technology Officer | 09/21/2016 | 2,004 |
| Slawin Kevin M. | Chief Technology Officer | 09/21/2016 | 2,004 |
| Moseley Ken | Sr. VP and General Counsel | 09/23/2016 | 87,399 |
| Moseley Ken | Sr. VP and General Counsel | 09/21/2016 | 747 |
| Moseley Ken | Sr. VP and General Counsel | 09/23/2016 | 235,198 |
| Moseley Ken | Sr. VP and General Counsel | 09/21/2016 | 2,004 |
| Slawin Kevin M. | Chief Technology Officer | 09/19/2016 | 28,024 |
| Slawin Kevin M. | Chief Technology Officer | 09/16/2016 | 12,720 |
| Slawin Kevin M. | Chief Technology Officer | 09/16/2016 | 18,840 |
| Slawin Kevin M. | Chief Technology Officer | 09/20/2016 | 2,000 |
| Slawin Kevin M. | Chief Technology Officer | 09/20/2016 | 6,000 |
| Slawin Kevin M. | Chief Technology Officer | 09/19/2016 | 24,129 |
| Spencer David M. | Chief Scientific Officer | 09/20/2016 | 2,000 |
| Spencer David M. | Chief Scientific Officer | 09/19/2016 | 14,013 |
| Spencer David M. | Chief Scientific Officer | 09/16/2016 | 34,015 |
| Moseley Ken | Sr. VP and General Counsel | 09/19/2016 | 9,711 |
| Moseley Ken | Sr. VP and General Counsel | 09/16/2016 | 5,229 |
| Moseley Ken | Sr. VP and General Counsel | 09/20/2016 | 1,494 |
| Moseley Ken | Sr. VP and General Counsel | 09/16/2016 | 14,000 |
| Moseley Ken | Sr. VP and General Counsel | 09/20/2016 | 4,000 |
| Moseley Ken | Sr. VP and General Counsel | 09/19/2016 | 26,018 |
| Slawin Kevin M. | Chief Technology Officer | 08/15/2016 | 598,931 |
| Slawin Kevin M. | Chief Technology Officer | 08/15/2016 | 695,012 |
| Spencer David M. | Chief Scientific Officer | 08/15/2016 | 20,000 |
| Moseley Ken | Sr. VP and General Counsel | 08/15/2016 | 7,470 |
| Moseley Ken | Sr. VP and General Counsel | 08/15/2016 | 20,000 |
| Slawin Kevin M. | Chief Technology Officer | 07/27/2016 | 225,000 |
| Spencer David M. | Chief Scientific Officer | 07/27/2016 | 150,000 |
| Slawin Kevin M. | Chief Technology Officer | 07/18/2016 | 38,044 |
| Slawin Kevin M. | Chief Technology Officer | 07/15/2016 | 305,677 |
| Moseley Annemarie | COO/EVP Clinical Development | 06/02/2016 | 63,750 |
| Moseley Annemarie | COO/EVP Clinical Development | 06/02/2016 | 325,000 |
| Moseley Ken | Sr. VP and General Counsel | 06/02/2016 | 38,250 |
| Moseley Ken | Sr. VP and General Counsel | 06/02/2016 | 195,000 |
| Slawin Kevin M. | Chief Technology Officer | 04/22/2016 | 342,788 |
| Slawin Kevin M. | Chief Technology Officer | 04/22/2016 | 285,710 |
| Moseley Annemarie | COO/EVP Clinical Development | 01/04/2016 | 89,250 |
| Moseley Annemarie | COO/EVP Clinical Development | 01/04/2016 | 667,494 |
| Spencer David M. | Chief Scientific Officer | 12/14/2015 | 12,750 |
| Spencer David M. | Chief Scientific Officer | 12/01/2015 | 114,739 |
| Musso Alan A | CFO and Treasurer | 11/24/2015 | 654,459 |
| Slawin Kevin M. | Chief Technology Officer | 11/16/2015 | 82,585 |
| Slawin Kevin M. | Chief Technology Officer | 11/16/2015 | 289,047 |
| Slawin Kevin M. | Chief Technology Officer | 11/16/2015 | 123,877 |
| Moseley Ken | Sr. VP and General Counsel | 11/02/2015 | 38,250 |
| Moseley Ken | Sr. VP and General Counsel | 11/02/2015 | 195,000 |
| Farrell Thomas J. | President and CEO | 10/01/2015 | 36,442 |
| Spencer David M. | Chief Scientific Officer | 09/21/2015 | 12,750 |
| Spencer David M. | Chief Scientific Officer | 09/11/2015 | 95,000 |
| Farrell Thomas J. | President and CEO | 09/01/2015 | 41,943 |
| Farrell Thomas J. | President and CEO | 08/03/2015 | 50,608 |
| Slawin Kevin M. | Chief Technology Officer | 07/15/2015 | 30,000 |
| Slawin Kevin M. | Chief Technology Officer | 07/15/2015 | 20,000 |
| Slawin Kevin M. | Chief Technology Officer | 07/15/2015 | 70,000 |
| Spencer David M. | Chief Scientific Officer | 07/02/2015 | 51,000 |
| Moseley Ken | Sr. VP and General Counsel | 07/01/2015 | 38,250 |
| Moseley Ken | Sr. VP and General Counsel | 07/01/2015 | 309,267 |
| Moseley Annemarie | COO/EVP Clinical Development | 07/01/2015 | 89,250 |
| Moseley Annemarie | COO/EVP Clinical Development | 07/01/2015 | 721,622 |
| Spencer David M. | Chief Scientific Officer | 06/16/2015 | 459,173 |
| Spencer David M. | Chief Scientific Officer | 06/16/2015 | 459,173 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR BELLICUM PHARMACEUTICALS INC
LOADING...